Dell Win Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 3197.55%
- Profit Growth 4248.82%
- Ebitda 1466.60%
- Net Worth 1920.13%
- Total Assets 255.84%
About Dell Win Pharmaceuticals
Dell Win Pharmaceuticals Private Limited (DWPPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 September 2019 (Five years and four months 22 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rami Marri and Sujatha Beeravalli serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100TG2019PTC135474
-
Company No.
135474
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 Sep 2019
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Dell Win Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rami Marri
|
Director | 17-Sep-2019 | Current |
|
Sujatha Beeravalli
|
Director | 17-Sep-2019 | Current |
Financial Performance of Dell Win Pharmaceuticals.
Dell Win Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 3197.55% increase. The company also saw a substantial improvement in profitability, with a 4248.82% increase in profit. The company's net worth Soared by an impressive increase of 1920.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dell Win Pharmaceuticals?
In 2021, Dell Win Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Bhuvika Life Sciences Private LimitedRami Marri and Sujatha Beeravalli are mutual person
-
Busyness365 Consulting Llp
Sujatha Beeravalli is a mutual person
-
Prazoles Pharma India Private Limited
Sujatha Beeravalli is a mutual person
-
Shanvika Digital Private Limited
Sujatha Beeravalli is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dell Win Pharmaceuticals?
Unlock and access historical data on people associated with Dell Win Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dell Win Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dell Win Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.